Integra Lifesciences Holdings (IART) Cash from Operations Growth (3y) (2012 - 2026)
Integra Lifesciences Holdings (IART) Cash from Operations Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | -48.14% |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | 50.11% |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | -14.75% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 0.50% |
| 10 | Integra Lifesciences Holdings | 1.50 Bn | 1.24 Bn | 216.98 Mn | -27.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.90% |
| Dec 31, 2025 | -48.27% |
| Sep 30, 2025 | -15.71% |
| Jun 30, 2025 | -48.81% |
| Mar 31, 2025 | -31.11% |
| Dec 31, 2024 | -9.86% |
| Sep 30, 2024 | -35.24% |
| Jun 30, 2024 | -23.79% |
| Mar 31, 2024 | -38.90% |
| Dec 31, 2023 | -9.88% |
| Sep 30, 2023 | -27.29% |
| Jun 30, 2023 | -5.13% |
| Mar 31, 2023 | 7.91% |
| Dec 31, 2022 | -1.46% |
| Sep 30, 2022 | 2.07% |
| Jun 30, 2022 | 11.06% |
| Mar 31, 2022 | 14.57% |
| Dec 31, 2021 | 17.52% |
| Sep 30, 2021 | 1.46% |
| Jun 30, 2021 | 36.10% |